Overview

VENLID: The Application of a 10%-Lidocaine Spray Prior to the Insertion of a Peripheral Intra-venous Catheter in Female Adults

Status:
NOT_YET_RECRUITING

Trial end date:
2024-05-01

Target enrollment:

Participant gender:

Summary

Volunteers are invited to undergo 4 insertions of a peripheral intra-venous 18-gauge catheter (PIVC); 2 insertions at the the start of the study on the plantar side of the hand/vessel at the dorsum manus, 2 insertions after 2-10 hours into the forearm/cubita with and without application of a 10-% lidocaine spray (5 hubs of xylocaine 10%-pump spray; AstraZeneca BV, Zoetermeer, The Netherlands) prior to the insertion of the PIVC.

Phase:

PHASE4

Details

Lead Sponsor:

Krankenhaus Barmherzige Schwestern Linz

Treatments:

Lidocaine